Graft-Versus-Host Disease (GVHD) Prophylaxis with Post-Transplant Cyclophosphamide (PTCY) Induces a More Tolerant Immune Response after Allogeneic Hematopoietic Cell Transplantation (Allo-HCT) in Patients Previously Exposed to Nivolumab

MLA

Carlos Palacio, et al. “Graft-Versus-Host Disease (GVHD) Prophylaxis with Post-Transplant Cyclophosphamide (PTCY) Induces a More Tolerant Immune Response after Allogeneic Hematopoietic Cell Transplantation (Allo-HCT) in Patients Previously Exposed to Nivolumab.” Blood, vol. 132, Nov. 2018, p. 3402. EBSCOhost, https://doi.org/10.1182/blood-2018-99-114887.

APA

Carlos Palacio, Laura Fox, Gloria Iacoboni, Marta Crespo, Francesc Bosch, Laura Gallur, Pere Barba, Elisa Roldán, Priyanka Raheja, Guillermo Ortí, Ana Perez, Lluis Puigdefàbregas, Olga Salamero, Júlia Carabia, Juan C. Nieto, Isabel Jiménez, & David Valcárcel. (2018). Graft-Versus-Host Disease (GVHD) Prophylaxis with Post-Transplant Cyclophosphamide (PTCY) Induces a More Tolerant Immune Response after Allogeneic Hematopoietic Cell Transplantation (Allo-HCT) in Patients Previously Exposed to Nivolumab. Blood, 132, 3402. https://doi.org/10.1182/blood-2018-99-114887

Chicago

Carlos Palacio, Laura Fox, Gloria Iacoboni, Marta Crespo, Francesc Bosch, Laura Gallur, Pere Barba, et al. 2018. “Graft-Versus-Host Disease (GVHD) Prophylaxis with Post-Transplant Cyclophosphamide (PTCY) Induces a More Tolerant Immune Response after Allogeneic Hematopoietic Cell Transplantation (Allo-HCT) in Patients Previously Exposed to Nivolumab.” Blood 132 (November): 3402. doi:10.1182/blood-2018-99-114887.